The nation’s monthslong shortage of highly potent cancer drugs is grinding on, forcing patients and their doctors to face even grimmer realities than that cancer typically presents. Several factors have contributed to the shortage of cancer drugs, and patients are hurting. What’s going on? At the heart of the problem is that US pharma companies have zero interest in manufacturing off-patent cancer drugs. They have sold the rights to foreign companies whose quality control is a huge issue. Here are the other issues.

The high cost of healthcare is a major problem in the United States. It is a problem that affects everyone, regardless of their income or health status. We need to find ways to reform the healthcare system so that it is more affordable and efficient, and so that everyone can get the care they need. We spend more on healthcare than any other country in the world, yet it has some of the worst health outcomes. This is a paradox that has been puzzling experts for years.